subject area of
- A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma Journal Articles
- A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia Journal Articles
- A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium Journal Articles
- Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome Journal Articles
- An International Survey on the Use of Thromboprophylaxis in Urological Surgery Journal Articles
- Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2) Journal Articles
- Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population Journal Articles
- Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA Journal Articles
- Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin Journal Articles
- Comorbidity Status Does Not Independently Predict Survival Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Journal Articles
- Complete Response as an Intermediate End Point in Patients Receiving Salvage Systemic Therapy for Urothelial Carcinoma Journal Articles
- Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients? Journal Articles
- Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial Journal Articles
- Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collaboration Journal Articles
- Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis Journal Articles
- Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors Journal Articles
- How long is long enough for pharmacological thromboprophylaxis in urology? Journal Articles
- Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma Journal Articles
- Impact of Response to Prior Chemotherapy in Patients With Advanced Urothelial Carcinoma Receiving Second-Line Therapy: Implications for Trial Design Journal Articles
- Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design Journal Articles
- Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design Journal Articles
- JAVELIN: avelumab another spear to fight urothelial carcinoma Journal Articles
- Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma Journal Articles
- Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma Journal Articles
-
Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (
PD )‐1 orPD ligand 1 inhibitor therapy Journal Articles - Pan-urologic cancer genomic subtypes that transcend tissue of origin Journal Articles
- Pediatric Urinary System Neoplasms Journal Articles
- Photodynamic Therapy for Urological Malignancies: Past to Current Approaches Journal Articles
- Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy Journal Articles
- Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma Journal Articles
- Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis Journal Articles
- Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma Journal Articles
- Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma. Journal Articles
- The Contemporary Role of Lymph Node Dissection During Nephroureterectomy in the Management of Upper Urinary Tract Urothelial Carcinoma: The Canadian Experience Journal Articles
- The Diagnostic Yield of CT Urography in the Workup of Hematuria With Negative Cystoscopy Journal Articles
- The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis Journal Articles
- The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review Journal Articles
- Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials Journal Articles
- Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10‐year population‐based analysis Journal Articles
- Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non–Lymph Node Distant Metastasis Journal Articles